We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Hydroxychloroquine and Aldesleukin in Renal Cell Carcinoma Patients (RCC)

This study is currently recruiting participants.
Verified December 2016 by Leonard Appleman, University of Pittsburgh
Sponsor:
ClinicalTrials.gov Identifier:
NCT01550367
First Posted: March 12, 2012
Last Update Posted: December 23, 2016
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Prometheus Laboratories
Information provided by (Responsible Party):
Leonard Appleman, University of Pittsburgh
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)